PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 129 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $258,689 | -75.3% | 9,366 | -79.4% | 0.00% | -80.0% |
| Q1 2023 | $1,045,879 | +24.5% | 45,473 | -40.9% | 0.01% | +25.0% |
| Q4 2022 | $839,961 | +29.4% | 76,990 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $649,000 | +15.7% | 76,990 | +8.5% | 0.00% | 0.0% |
| Q2 2022 | $561,000 | -54.3% | 70,930 | +49.7% | 0.00% | -50.0% |
| Q1 2021 | $1,227,000 | +26.8% | 47,387 | -1.3% | 0.01% | +50.0% |
| Q4 2020 | $968,000 | +6.0% | 48,007 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $913,000 | +10.7% | 46,707 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $825,000 | +300.5% | 46,707 | +60.4% | 0.00% | +300.0% |
| Q1 2020 | $206,000 | – | 29,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |